- Home
- ATXS vs TRAK Comparison
ATXS vs TRAK Comparison
Compare ATXS & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- TRAK
- Stock Information
- Founded
- ATXS 2008
- TRAK 1990
- Country
- ATXS United States
- TRAK United States
- Employees
- ATXS N/A
- TRAK N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- TRAK EDP Services
- Sector
- ATXS Health Care
- TRAK Technology
- Exchange
- ATXS Nasdaq
- TRAK Nasdaq
- Market Cap
- ATXS 401.2M
- TRAK 366.3M
- IPO Year
- ATXS 2015
- TRAK 1998
- Fundamental
- Price
- ATXS $4.04
- TRAK $20.19
- Analyst Decision
- ATXS Strong Buy
- TRAK Strong Buy
- Analyst Count
- ATXS 5
- TRAK 1
- Target Price
- ATXS $26.60
- TRAK $24.00
- AVG Volume (30 Days)
- ATXS 369.7K
- TRAK 59.4K
- Earning Date
- ATXS 05-08-2025
- TRAK 05-14-2025
- Dividend Yield
- ATXS N/A
- TRAK 0.36%
- EPS Growth
- ATXS N/A
- TRAK 14.28
- EPS
- ATXS N/A
- TRAK 0.32
- Revenue
- ATXS N/A
- TRAK $21,199,507.00
- Revenue This Year
- ATXS N/A
- TRAK $15.61
- Revenue Next Year
- ATXS N/A
- TRAK $15.00
- P/E Ratio
- ATXS N/A
- TRAK $63.13
- Revenue Growth
- ATXS N/A
- TRAK 6.99
- 52 Week Low
- ATXS $3.56
- TRAK $14.23
- 52 Week High
- ATXS $12.92
- TRAK $25.01
- Technical
- Relative Strength Index (RSI)
- ATXS 28.96
- TRAK 54.14
- Support Level
- ATXS $3.56
- TRAK $19.79
- Resistance Level
- ATXS $4.39
- TRAK $20.37
- Average True Range (ATR)
- ATXS 0.42
- TRAK 1.05
- MACD
- ATXS -0.04
- TRAK 0.14
- Stochastic Oscillator
- ATXS 22.61
- TRAK 89.94
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.